“mint Lesion™ enables us to make better reports because it truly provides all the necessary data for patient care.”
Dr. Laurent Chapuis shares how the software solution mint Lesion™ makes the multitude of initial stagings and follow up assessments for oncology patients they perform at Clinique de la Source Lausanne easier to manage. The “very good approach to tumor assessment” which mint Lesion™ offers, aids clinicians in their treatment of patients and could be integrated into their workflow without disrupting it.
Structured reports for better patient care in oncology
Related Resources
Related Resources
University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy
A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…
Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™
Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…
Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations
A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on…